Icon

ONSOLIS - (0.2MG, 0.4MG, 0.6MG, 0.8MG, 1.2MG)

FENTANYL CITRATE None
0.2MG, 0.4MG, 0.6MG, 0.8MG, 1.2MG
Less Than $1000 mn
None None
None None
None None
ONSOLIS is an opioid agonist indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain.
Yes
ONSOLIS Patent 1 Patent 2 Patent 3 Patent 4
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.